Shwen Gwee, Novartis Biome

Shwen Gwee


1:40 PM - 2:05 PM

Realizing the Potential of Virtual and Hybrid Clinical Trials

The need to increase the speed of patient recruitment, improve retention, and enhance data quality – all while lowering costs, has led to the current interest in virtual and hybrid clinical trials. The question is, how do you know when a virtual or hybrid study makes sense? This session will focus on the critical differences between traditional and virtual or hybrid trials that need to be considered.

  • What therapeutic areas are most effective using virtual and hybrid trials?
  • The importance of protocol design and a distribution and tracking plan for medication.
  • What steps need to be taken to ensure the safety of patients?
  • If the home is the new trial site, how is that different? What do you need to do differently from the start of the process through the end of the trial?
  • Understanding How Digital Therapeutics Will Change the Clinical Trial Paradigm.


  • Nitin Naik

    Nitin Naik Vice President-Global Life Sciences, Transformational Health Frost & Sullivan


  • Shwen Gwee

    Shwen Gwee Co-Founder & Global Head of Open Innovation Novartis Biome

Download Latest Agenda